New Products and Industry News
New hand antiseptic improves hand hygiene
3M Health Care (St. Paul, MN) launched Avagard Foam Instant Hand Antiseptic with Moisturizers, the newest addition to their Avagard hand hygiene products.
The foam antiseptic contains a blend of five different emollients designed to moisturize and condition hands while it disinfects. The product dries quickly and spreads easily while avoiding aerosol can disposal costs.
For more information, visit www.3m.com.
All-in-one wound management solution introduced
Andover Healthcare Inc (Andover, MA) introduced CoFlex® AFD, an all-in-one foam pad dressing and cohesive bandage. The product’s absorbent foam pad is attached to a CoFlex LF2 compression bandage for easy application, which allows it to stick to itself without clips or fasteners while providing controlled compression.
The product’s applications and uses range from treating venous leg ulcers and pressure ulcers to treating traumatic wounds, non-healing surgical incisions, and skin tears.
For more information, visit www.andover-healthcare.com.
Collagen technology targets MMPs
Smith & Nephew Advanced Wound Management (London, UK; Largo, FL) launched two collagen dressing products that deactivate harmful wound matrix metalloproteases and help maintain an optimal wound healing environment. BIOSTEP features a 6-day wear time; BIOSTEP Ag combines anti-MMP activity with the antimicrobial activity of silver to help minimize infection risk.
For more information, visit www.smith-nephew.com.
Post-op abdominal binder offers support and pressure control
Dale Medical Products Inc (Plainville, MA) recently unveiled The Dale® Abdominal Binder, a new post-op abdominal binder that features a Velcro® strip that secures tubing and drainage bulbs without pins or tape.
The product comprises a fully adjustable support system that provides total circumferential compression and allows the healthcare provider control over the pressure being applied to the abdomen.
For more information, visit www.dalemed.com.
New delivery system for topical therapy
Coria Laboratories (Fort Worth, TX) recently created a new delivery system for their mid-potency corticosteroid Cloderm® Cream, a product commonly prescribed for inflammation, pruritus associated with dermatoses, and a variety of dermatitis.
The product’s pump automatically controls the amount of cream dispensed for greater precision and safety, minimizes waste, is highly portable, and is easy to store.
For more information, visit www.corialabs.com.
Drug reported effective against nail infections
OrthoNeutrogenas (Skillman, NJ) Ertaczo™ is a sweat-resistant antifungal cream proving to be effective against athlete’s foot (tinea pedis), a predictive factor for the nail infection onychomycosis. The product”s ability to treat these infections comes from its active ingredient, sertaconazole nitrate; its prolonged dermal retention improves the likelihood of complete eradication of athlete’s foot and protects against future reinfections.
For more information, visit www.aboutertaczo.com.
New trial for treatment of non-healing diabetic foot ulcers
Cardium Therapeutics (San Diego, CA) and its subsidiary, the Tissue Repair Company, announced the start of its Phase IIb clinical trial to evaluate the efficacy of Excellarate™ for the potential treatment of non-healing diabetic foot ulcers.
The product is a DNA-based topical gel being developed to help stimulate wound healing. Utilizing the Tissue Repair Company’s Gene Activated Matrix™ technology and platelet-derived growth factor-BB protein (PDGF-BB), the product stimulates angiogenesis and granulation tissue formation through the proliferation of cells such as monocytes, fibroblasts, and endothelial cells necessary for the wound healing processes.
For more information, visit www.cardiumthx.com.
